×
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
LON:IDH

Immunodiagnostic Systems (IDH) Share Forecast, Price & News

GBX 378
0.00 (0.00%)
(As of 07/12/2021)
Add
Compare
Today's Range
378
378
50-Day Range
378
378
52-Week Range
180
380
Volume
N/A
Average Volume
14,539 shs
Market Capitalization
£108.80 million
P/E Ratio
290.77
Dividend Yield
0.50%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive IDH News and Ratings via Email

Sign-up to receive the latest news and ratings for Immunodiagnostic Systems and its competitors with MarketBeat's FREE daily newsletter.

Immunodiagnostic Systems logo

About Immunodiagnostic Systems

Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. The company provides its products and services for diagnosis of bone metabolism, calcium metabolism, hypertension, chronic kidney disease mineral bone disorder, growth, fertility, autoimmunity, infectious disease, sarcoidosis, and allergy. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medical Appliances & Equipment
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Sales & Book Value

Annual Sales
£34.25 million
Cash Flow
GBX 84 per share
Book Value
GBX 187.60 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£108.80 million
Optionable
Not Optionable

Company Calendar

Last Earnings
6/20/2018
Today
5/27/2022

MarketRank

Overall MarketRank

0.83 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Immunodiagnostic Systems (LON:IDH) Frequently Asked Questions

How were Immunodiagnostic Systems' earnings last quarter?

Immunodiagnostic Systems Holdings PLC (LON:IDH) announced its earnings results on Wednesday, June, 20th. The company reported $5.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.60 by $3.10.
View Immunodiagnostic Systems' earnings history
.

Is Immunodiagnostic Systems a good dividend stock?

Immunodiagnostic Systems pays an annual dividend of GBX 0.02 per share and currently has a dividend yield of 0.50%. The dividend payout ratio of Immunodiagnostic Systems is 1.46%. This payout ratio is at a healthy, sustainable level, below 75%.
View Immunodiagnostic Systems' dividend history.

Who are Immunodiagnostic Systems' key executives?
Immunodiagnostic Systems' management team includes the following people:
  • Mr. Jaap Stuut, CEO & Director (Age 51, Pay $284k)
  • Mr. Paul J. Martin, Group Fin. Director, Company Sec. & Director
  • Mr. Sander Perret Gentil, Head of Marketing & Communications
  • Nicola Mitton, Group HR Director
  • Mr. Ed Coombes, Head Of Bus. Devel. - Instrumentation (Age 50)
  • Dr. Rudolf Schemer Ph.D., CEO of GeschTMaftsfuhrer at IDS GmbH Frankfurt & Country Mang. of Germany Region (Age 60)
What other stocks do shareholders of Immunodiagnostic Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Immunodiagnostic Systems investors own include Dechra Pharmaceuticals (DPH), iShares Biotechnology ETF (IBB), Redrow (RDW), Netflix (NFLX), Sysco (SYY), TP ICAP Group (TCAP), Telford Homes (TEF), WisdomTree U.S. Multifactor Fund (USMF), American Tower (AMT) and Advanced Medical Solutions Group (AMS).

What is Immunodiagnostic Systems' stock symbol?

Immunodiagnostic Systems trades on the London Stock Exchange (LON) under the ticker symbol "IDH."

How do I buy shares of Immunodiagnostic Systems?

Shares of IDH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Immunodiagnostic Systems' stock price today?

One share of IDH stock can currently be purchased for approximately GBX 378.

How much money does Immunodiagnostic Systems make?

Immunodiagnostic Systems has a market capitalization of £108.80 million and generates £34.25 million in revenue each year.

How many employees does Immunodiagnostic Systems have?

Immunodiagnostic Systems employs 147,000 workers across the globe.

What is Immunodiagnostic Systems' official website?

The official website for Immunodiagnostic Systems is www.idsplc.com.

How can I contact Immunodiagnostic Systems?

Immunodiagnostic Systems' mailing address is 10 Didcot Way, BOLDON, NE35 9PD, United Kingdom. The company can be reached via phone at +44-191-5190660.

This page was last updated on 5/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.